Pfizer is working to deal with typical business issues in the drug space, but its attempt at a solution has become very ...

NYSE:PFE Earnings and Revenue History November 11th 2025 How Do Unusual Items Influence Profit? To properly understand Pfizer ...

Pfizer › A strong quarter and earnings beat can sometimes give a stock a big boost. But when that doesn't happen, it usually means there are other factors that are weighing on a business and give ...

Novo Nordisk (NYSE:NVO) climbs about 2% on Monday afternoon after it says it will not raise its offer for Metsera ...

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) slugging it out, while Pfizer ...

Wall Street's main indexes gained on Monday, following signs of progress in Washington to end a record government shutdown ...

The prolonged shutdown has taken a toll on consumer confidence and the overall economy, with consumer sentiment dropping to ...

The first thing that comes to mind when we speak about the S&P 500 is the biggest tech companies, high valuations, and ...

Equity markets delivered a mixed response after Pfizer won the bidding war for anti-obesity drugmaker Metsera, as Metsera’s ...

Novo Nordisk A/S posted solid revenue and profit increases, with a resilient pipeline and strong dividend yield. Learn more ...

Wall Street ended sharply higher on Monday, led by big gains in Nvidia, Palantir and other heavyweight AI-related companies ...

VYM has gained 9.9% in 2025 and has generated a cumulative 3-year return of 44.38% and a 5-year return of 105.33%. It remains ...